NCT07042100
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07042100
Title A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sun Pharma Advanced Research Company Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS


No variant requirements are available.